What Continuous Glucose Monitors Miss: A Critical Glance at Wearable Health Data

Continuous glucose monitors (CGMs) have become increasingly popular, not just among people with diabetes but also among those seeking to optimize their health through real-time data. However, a growing body of evidence suggests that constant glucose monitoring may not deliver the health benefits many users expect—and could even cause harm.

According to experts studying wearable health data, the promise of CGMs for non-diabetic individuals often falls short. While these devices provide a steady stream of glucose readings, interpreting that data to make meaningful health decisions remains a significant challenge. As noted in a recent Washington Post guest column, monitoring glucose continuously does not necessarily help people make better health choices and can instead lead to confusion and unnecessary anxiety.

The Limits of Glucose Data Alone

Glucose levels fluctuate naturally throughout the day in response to food, activity, stress, and sleep. For people without diabetes, these variations typically remain within a healthy range and do not require intervention. Yet, CGM users without diabetes may misinterpret normal fluctuations as problematic, prompting restrictive diets or excessive exercise based on incomplete information.

Research indicates that simply having more data does not equate to better health outcomes. A review published in the Alexandria Engineering Journal highlights that while CGM technology has advanced significantly, integrating this data with artificial intelligence to generate actionable insights remains complex. Even with AI-assisted analysis, the clinical value for non-diabetic populations is not yet well established.

Psychological Risks of Over-Monitoring

One of the most concerning aspects of widespread CGM leverage among healthy individuals is the potential for increased health anxiety. Constantly tracking glucose can turn everyday eating into a source of stress, leading to behaviors reminiscent of orthorexia or disordered eating. The American Council on Science and Health has described this phenomenon as “doomscrolling” with health data—where users become fixated on minor variations, interpreting them as signs of impending dysfunction.

This trend is particularly troubling given that the FDA granted breakthrough device designation in 2022 to a CGM for use by people without diabetes, signaling growing commercial interest in expanding the market beyond traditional diabetic populations. Critics argue that such moves prioritize innovation over evidence, potentially exposing users to psychological risks without proven benefits.

When CGMs Are Truly Valuable

It is important to emphasize that CGMs remain indispensable tools for people with diabetes. For individuals managing type 1 or type 2 diabetes, real-time glucose tracking can prevent dangerous highs and lows, improve long-term control, and reduce the risk of complications. In these cases, the benefits of continuous monitoring far outweigh the drawbacks.

CGMs are valuable in clinical research settings, helping scientists understand metabolic responses to diet, exercise, and medication. When used under medical supervision and paired with professional guidance, the data can support personalized health strategies.

A Balanced Approach to Wearable Health Technology

As wearable devices become more sophisticated, the focus should shift from mere data collection to meaningful interpretation and clinical relevance. Experts recommend that individuals considering CGM use—especially those without diabetes—consult with healthcare providers to understand the limitations and potential downsides.

Rather than chasing perfect glucose stability, a more sustainable approach involves paying attention to overall well-being: balanced nutrition, regular physical activity, adequate sleep, and stress management. These foundational habits influence glucose metabolism far more than any single data point from a wearable device.

while continuous glucose monitors represent a remarkable technological achievement, they are not a shortcut to health. True wellness comes not from obsessing over numbers, but from cultivating habits that support long-term vitality—guided by evidence, not anxiety.

Key Takeaways

• Continuous glucose monitors provide real-time data but do not automatically lead to better health decisions for non-diabetic individuals.
• Constant glucose tracking can cause confusion, anxiety, and unhealthy fixation on normal fluctuations.
• CGMs are essential and beneficial for people with diabetes but lack proven value for healthy populations.
• More data does not equal better health; context, interpretation, and professional guidance are crucial.
• Focus on foundational lifestyle habits rather than micromanaging glucose levels through wearable technology.